PRS28 ADD-ON OMALIZUMAB IN PERSISTENT DIFFICULT-TO-TREAT ASTHMA: A 12-MONTH STUDY ON CLINICAL, ECONOMIC OUTCOMES AND RELATED COST/UTILITY

• 作者RW Dal Negro; L Pradelli; C Micheletto; S Tognella; S Iannazzo
• 卷第12卷
• 期第7期
• 文件大小91.85KB
• 发表时间2009
• DOI10.1016/s1098-3015(10)74490-9